By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Northwest Biotherapeutics, Inc. 

21720 23rd Drive SE
Suite 100
Bothell  Washington  98021  U.S.A.
Phone: 425-608-3000-or-877-606-9246-Toll-Free Fax: 425-608-3026




Cytogen Corporation  Development of ex vivo prostate cancer immunotherapy

Company News
NW Bio (NWBO) Announces Operations Updates 5/3/2016 9:24:32 AM
NW Bio (NWBO) Announces Registered Direct Offering Of Up To $27.6 Million With Existing Institutional Investors 2/29/2016 9:40:01 AM
Comments by Principal Investigator the Real Reason NW Bio (NWBO)'s Stock Tanked Last Fall 2/10/2016 7:28:44 AM
NW Bio (NWBO) Announces Appointment Of Two New Independent Directors With Biotech/Pharma Expertise and Cybersecurity/Investigations Expertise 1/25/2016 7:53:24 AM
NW Bio (NWBO) Presenting At Phacilitate Immunotherapy World Forum 1/25/2016 7:35:32 AM
NW Bio (NWBO) Issues Statement On Adverse Market Conditions And NW Bio Stock Decline 1/8/2016 8:09:26 AM
NW Bio (NWBO) Announces Closing Of Registered Direct Offering Of $12.6 Million 12/28/2015 6:35:34 AM
NW Bio (NWBO) Announces A Registered Direct Offering Of $12.6 Million 12/23/2015 7:13:35 AM
NW Bio (NWBO) Announces Annual Meeting Results, Re-Election of Directors 12/21/2015 11:46:18 AM
NW Bio (NWBO) Statement Regarding Appointments 12/8/2015 12:19:32 PM